Data sourced from ClinicalTrials.gov (NIH registry) Updated weekly IRB-supervised studies only
Home/AR/Fayetteville
Updated October 2026 from ClinicalTrials.gov

Paid Clinical Trials in Fayetteville, AR

Studies commonly pay $75 to $4,500 per completed study

126 clinical trials are currently recruiting participants within 30 miles of Fayetteville. Listings below come straight from the official NIH registry, alongside the area's top-rated research centers with real Google reviews.

126studies recruiting
9+research centers nearby
3condition categories
Live from the NIH registry

Studies recruiting near Fayetteville right now

Top 25 of 126 recruiting studies, sorted by proximity — each links to its official registry page

An Open-label Study Comparing Lutetium (177Lu) Vipivotide Tetraxetan Versus Observation in PSMA Positive OMPC.

Oligometastatic Prostate Cancer (OMPC) Phase 3 Interventional 450 participants sought
Highlands Oncology Group — Fayetteville, Arkansas (0.8 mi) · Sponsor: Novartis Pharmaceuticals
See eligibility & contact on ClinicalTrials.gov (NCT05939414)

The Effects of Cannabigerol on Attention-Deficit/Hyperactivity Disorder

Attention-Deficit/Hyperactivity Disorder Phase 2 Interventional 76 participants sought
University of Arkansas — Fayetteville, Arkansas (0.8 mi) · Sponsor: University of Arkansas, Fayetteville
See eligibility & contact on ClinicalTrials.gov (NCT06115603)

Sacituzumab Govitecan With Bevacizumab Compared to Usual Chemotherapy (Carboplatin, Pegylated Liposomal Doxorubicin and Bevacizumab) for Treating Recurrent Platinum-Sensitive Ovarian Cancer After PARP Inhibitor Maintenance Therapy

Recurrent Platinum-Sensitive Fallopian Tube Endometrioid Adenocarcinoma, Recurrent Platinum-Sensitive Fallopian Tube High Grade Serous Adenocarcinoma Phase 2 Interventional 87 participants sought
Highlands Oncology Group - Fayetteville — Fayetteville, Arkansas (0.8 mi) · Sponsor: National Cancer Institute (NCI)
See eligibility & contact on ClinicalTrials.gov (NCT07504588)

A Study of Nemtabrutinib Plus Venetoclax vs Venetoclax + Rituximab (VR) in Second-line (2L) + Relapsed/Refractory (R/R) Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL) (MK-1026-010/BELLWAVE-010).

Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Chronic Lymphocytic Phase 3 Interventional 735 participants sought
Highlands Oncology Group ( Site 5405) — Springdale, Arkansas (8.2 mi) · Sponsor: Merck Sharp & Dohme LLC
See eligibility & contact on ClinicalTrials.gov (NCT05947851)

ROSETTA Breast-01: The Effects and Safety of Pumitamig in Patients With Triple-Negative Breast Cancer

Breast Neoplasms Phase 3 Interventional 558 participants sought
Highlands Oncology Group — Springdale, Arkansas (8.2 mi) · Sponsor: BioNTech SE
See eligibility & contact on ClinicalTrials.gov (NCT07173751)

A Study to Assess Efficacy and Safety of Pembrolizumab With or Without Sacituzumab Tirumotecan (MK- 2870) in Adult Participants With Resectable Non Small Cell Lung Cancer (NSCLC) Not Achieving Pathological Complete Response (pCR) (MK-2870-019)

Non Small Cell Lung Cancer Phase 3 Interventional 780 participants sought
Highlands Oncology Group-Research Department ( Site 0062) — Springdale, Arkansas (8.2 mi) · Sponsor: Merck Sharp & Dohme LLC
See eligibility & contact on ClinicalTrials.gov (NCT06312137)

Shorter Chemo-Immunotherapy Without Anthracycline Drugs for Early-Stage Triple Negative Breast Cancer

Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8 Phase 3 Interventional 2,400 participants sought
Highlands Oncology Group - Fayetteville — Fayetteville, Arkansas (0.8 mi) · Sponsor: SWOG Cancer Research Network
See eligibility & contact on ClinicalTrials.gov (NCT05929768)

Study of Silevertinib With Temozolomide for the Treatment of Newly Diagnosed GBM With Unmethylated MGMT and EGFRvIII

Glioblastoma (GBM), Newly Diagnosed Glioblastoma Phase 2 Interventional 162 participants sought
Highlands Oncology Group — Springdale, Arkansas (8.2 mi) · Sponsor: Black Diamond Therapeutics, Inc.
See eligibility & contact on ClinicalTrials.gov (NCT07326566)

Testing the Role of DNA Released From Tumor Cells Into the Blood in Guiding the Use of Immunotherapy After Surgical Removal of the Bladder, Kidney, Ureter, and Urethra for Urothelial Cancer Treatment, MODERN Study

Muscle Invasive Bladder Urothelial Carcinoma, Muscle Invasive Renal Pelvis Urothelial Carcinoma Phase 2, Phase 3 Interventional 992 participants sought
Highlands Oncology Group - Fayetteville — Fayetteville, Arkansas (0.8 mi) · Sponsor: National Cancer Institute (NCI)
See eligibility & contact on ClinicalTrials.gov (NCT05987241)

Comparing Rituximab and Mosunetuzumab Drug Treatments for People With Low Tumor Burden Follicular Lymphoma

Classic Follicular Lymphoma, Follicular Lymphoma With Unusual Cytological Features Phase 3 Interventional 600 participants sought
Highlands Oncology Group - Fayetteville — Fayetteville, Arkansas (0.8 mi) · Sponsor: National Cancer Institute (NCI)
See eligibility & contact on ClinicalTrials.gov (NCT06337318)

Phase III, Open-label, Study of First-line Dato-DXd in Combination With Rilvegostomig for Advanced Non-squamous NSCLC With High PD-L1 Expression (TC ≥ 50%) and Without Actionable Genomic Alterations

Non-Small Cell Lung Cancer Phase 3 Interventional 675 participants sought
Research Site — Springdale, Arkansas (8.2 mi) · Sponsor: AstraZeneca
See eligibility & contact on ClinicalTrials.gov (NCT06357533)

A Study to Evaluate the Efficacy and Safety of Autogene Cevumeran With Nivolumab Versus Nivolumab Alone in Participants With High-risk Muscle-invasive Urothelial Carcinoma (MIUC)

Muscle-invasive Urothelial Carcinoma Phase 2 Interventional 62 participants sought
Highlands Oncology Group. — Springdale, Arkansas (8.2 mi) · Sponsor: Hoffmann-La Roche
See eligibility & contact on ClinicalTrials.gov (NCT06534983)

A Study to Investigate the Efficacy and Safety of Dato-DXd With or Without Osimertinib Compared With Platinum Based Doublet Chemotherapy in Participants With EGFR-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer

Metastatic Non-small Cell Lung Cancer Phase 3 Interventional 744 participants sought
Research Site — Fayetteville, Arkansas (0.8 mi) · Sponsor: AstraZeneca
See eligibility & contact on ClinicalTrials.gov (NCT06417814)

A Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for First-Line Treatment of Locally Advanced or Metastatic Squamous Non-small Cell Lung Cancer (NSCLC)

Non-small Cell Lung Cancer Phase 3 Interventional 1,160 participants sought
Research Site — Springdale, Arkansas (8.2 mi) · Sponsor: AstraZeneca
See eligibility & contact on ClinicalTrials.gov (NCT06692738)

Candida Therapeutic Vaccine in Head and Neck Cancer Patients to Reduce Recurrence

Squamous Cell Carcinoma of Head and Neck Phase 2 Interventional 100 participants sought
Highlands Oncology Group, PA — Fayetteville, Arkansas (0.8 mi) · Sponsor: University of Arkansas
See eligibility & contact on ClinicalTrials.gov (NCT05952934)

A Study to Compare the PK Characteristics, Safety, Tolerability, and Immunogenicity of HLX15-SC With DARZALEX FASPRO® in Combination With Lenalidomide and Dexamethasone (Rd) in Transplant-ineligible Patients With Newly Diagnosed Multiple Myeloma

Multiple Myeloma (MM) Phase 1 Interventional 258 participants sought
Highlands Oncology Group, PA — Springdale, Arkansas (8.2 mi) · Sponsor: Shanghai Henlius Biotech
See eligibility & contact on ClinicalTrials.gov (NCT07477587)

Chemotherapy Combined With Immunotherapy Versus Immunotherapy Alone for Older Adults With Stage IIIB-IV Lung Cancer, The ACHIEVE Trial

Advanced Lung Non-Small Cell Carcinoma, Stage IIIB Lung Cancer AJCC v8 Phase 3 Interventional 304 participants sought
Highlands Oncology Group - Fayetteville — Fayetteville, Arkansas (0.8 mi) · Sponsor: National Cancer Institute (NCI)
See eligibility & contact on ClinicalTrials.gov (NCT06096844)

A Study Investigating Subcutaneously Administered Pozelimab in Combination With Cemdisiran or Cemdisiran Alone in Adult Participants With Geographic Atrophy

Age-related Macular Degeneration (AMD), Geographic Atrophy (GA) Phase 3 Interventional 975 participants sought
Retina Partners of Northwest Arkansas, PLLC — Springdale, Arkansas (8.2 mi) · Sponsor: Regeneron Pharmaceuticals
See eligibility & contact on ClinicalTrials.gov (NCT06541704)

A Study of Amivantamab and FOLFIRI Versus Cetuximab/Bevacizumab and FOLFIRI in Participants With KRAS/NRAS and BRAF Wild-type Colorectal Cancer Who Have Previously Received Chemotherapy

Colorectal Neoplasms Phase 3 Interventional 700 participants sought
Highlands Oncology Group — Springdale, Arkansas (8.2 mi) · Sponsor: Janssen Research & Development, LLC
See eligibility & contact on ClinicalTrials.gov (NCT06750094)

A Randomized Study of Azetukalner Versus Placebo in Major Depressive Disorder

Major Depressive Disorder Phase 3 Interventional 450 participants sought
Woodland Research Northwest — Rogers, Arkansas (18.2 mi) · Sponsor: Xenon Pharmaceuticals Inc.
See eligibility & contact on ClinicalTrials.gov (NCT06775379)

Evaluation of SPN-812 (Viloxazine Extended-release Capsule) in Preschool-age Children With ADHD

Attention-Deficit/Hyperactivity Disorder Phase 4 Interventional 286 participants sought
Preferred Research Partners-NWA, LLC — Fayetteville, Arkansas (0.8 mi) · Sponsor: Supernus Pharmaceuticals, Inc.
See eligibility & contact on ClinicalTrials.gov (NCT04781140)

Testing Drug Treatments After CAR T-cell Therapy in Patients With Relapsed/Refractory Diffuse Large B-cell Lymphoma

Diffuse Large B-Cell Lymphoma, Grade 3b Follicular Lymphoma Phase 2 Interventional 396 participants sought
Highlands Oncology Group - Fayetteville — Fayetteville, Arkansas (0.8 mi) · Sponsor: SWOG Cancer Research Network
See eligibility & contact on ClinicalTrials.gov (NCT05633615)

Combining Immunotherapy and Radiation Therapy to Help Patients Avoid Bladder Removal After Treatment Shrinks Muscle Invasive Bladder Cancer, BRIGHT Trial

Muscle Invasive Bladder Urothelial Carcinoma, Stage II Bladder Cancer AJCC v8 Phase 2 Interventional 111 participants sought
Highlands Oncology Group - Fayetteville — Fayetteville, Arkansas (0.8 mi) · Sponsor: National Cancer Institute (NCI)
See eligibility & contact on ClinicalTrials.gov (NCT07061964)

Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combination in Patients With a KRAS G12C Mutation KRYSTAL-7

Advanced Non-Small Cell Lung Cancer, Metastatic Non-Small Cell Lung Cancer Phase 2, Phase 3 Interventional 626 participants sought
Highlands Oncology Group - Springdale — Springdale, Arkansas (8.2 mi) · Sponsor: Mirati Therapeutics Inc.
See eligibility & contact on ClinicalTrials.gov (NCT04613596)
Actively enrolling

Studies you may be able to join near Fayetteville

These studies are recruiting through partner research networks. We may be paid a referral fee if you complete their screening form — this never changes what you pay (nothing) or the compensation the study offers you.

See which clinical studies you may qualify for

A partner research network matches volunteers with studies that are currently enrolling in the United States. You answer a few screening questions about your health and where you live; if a study looks like a fit, its team contacts you to confirm eligibility.

Screening is free and takes a few minutes. Eligibility and any compensation are confirmed by the study team, not by this site.

Check your eligibility
Google-rated

Top-rated research centers in Fayetteville

Dedicated clinical research sites near you — with their real Google ratings, reviews and contact details

Health Initiatives Research

2233 Green Acres Rd, Fayetteville, AR 72703
(479) 575-9600

Clinical Trials Institute of Northwest Arkansas

1651 E Stearns St #110, Fayetteville, AR 72703
(479) 544-3483

UAMS Northwest Regional Campus

★ 3.8
1125 N College Ave, Fayetteville, AR 72703
(479) 713-8000

The Spero Clinic

★ 4.9 (242 reviews)
22 Colt Square Dr, Fayetteville, AR 72703
(479) 333-8422

Woodland Research Northwest

★ 4.3
609 W Dyke Rd, Rogers, AR 72758
(479) 927-3000

Pat Walker Health Center

★ 3.0
525 Garland Ave, Fayetteville, AR 72701
(479) 575-4451
"The ladies at the front desk are very welcoming and friendly. They are very outgoing and were more than happy to help me. I really appreciate the tim…"
— Miller Johnston, 5★

Pillar Clinical Research, Bentonville, Arkansas

★ 4.9
3200 NE Redhawk Dr, Bentonville, AR 72712
(479) 367-2688
"⭐⭐⭐⭐⭐<br><br>I had a great experience with Pillar Clinical Research. The staff was friendly, professional, and made me feel comfortable from the…"
— elexis Thomas, 5★

C & C Market Research

★ 4.1
4201 N Shiloh Dr #1820, Fayetteville, AR 72703
(479) 582-1127
"Tried calling the number says been disconnected ☹️😡"
— Elizabeth Ritcheson (Bettyjo), 1★

Northwest Arkansas Clinical Trials Center, PLLC

★ 5.0
599 S Horsebarn Rd #200, Rogers, AR 72758
(479) 876-8205

Clinical trials in Fayetteville: what's recruiting

The Fayetteville area currently has 126 studies open to new participants, according to the ClinicalTrials.gov registry maintained by the U.S. National Institutes of Health. Among the studies closest to Fayetteville, the most active research areas are:

  • Cancer & Oncology19 studies
  • Liver & Kidney1 studies
  • Brain & Mental Health1 studies

Every listing shows the study phase, the recruiting site and its distance from Fayetteville, and links to the official registry page where eligibility criteria and study contacts are published. Compensation is set by each sponsor: industry surveys report typical payments of $75 to $4,500 per completed study, with short observational studies at the low end and multi-visit or overnight Phase 1 studies at the high end.

How to enroll in a paid study in Fayetteville

Start with a study whose condition matches your profile — or a healthy-volunteer study if you have no diagnosis. Contact the research site through the registry page, complete a short phone screen, then attend an in-person screening visit. If you qualify, the study team walks you through the informed consent document, which details every procedure, risk and payment before you commit. You can withdraw at any point, and enrollment is always free.

Fayetteville participants can also register with the dedicated research centers listed above — many maintain volunteer databases and call when a matching study opens — or sign up for our email alert below to hear when a new study starts recruiting within 30 miles of your ZIP code.

Frequently asked questions

How much do paid clinical trials in Fayetteville pay?
Compensation varies by study length, procedures and overnight stays. Industry surveys report typical payments from $75 to $4,500 per completed study, with simple observational studies at the low end and multi-week inpatient Phase 1 studies at the high end. Each listing's study team will confirm the exact amount before you enroll.
Are clinical trials in Fayetteville safe?
Every trial on this page is registered on ClinicalTrials.gov, the official NIH registry, and is overseen by an Institutional Review Board (IRB). Before joining you receive an informed consent document detailing procedures, risks and compensation. Participation is voluntary and you can withdraw at any time.
Is compensation for clinical trials taxable?
In the U.S., clinical trial compensation is generally considered taxable income, and research sites may issue a 1099 form for payments above $600 in a year. Reimbursements for travel or meals are typically treated differently. Consult a tax professional for your situation.
How often do new paid studies open in Fayetteville?
Constantly — trials open and close enrollment every week. This page is refreshed weekly from the NIH registry. Join the email alert to be notified when a new study opens within 30 miles of Fayetteville.
Can I be in more than one clinical trial at a time?
Generally no — most studies exclude participants currently enrolled in another trial, and paid Phase 1 studies enforce a washout period (often 30 days or more) between studies. Frequent healthy volunteers in Fayetteville typically complete one or two studies per year.

Paid clinical trials near Fayetteville

Other metros within reach

Springfield, MO153 Tulsa, OK185 Little Rock, AR513 Overland Park, KS1,034 Olathe, KS1,042 Kansas City, MO1,035 Kansas City, KS1,046 Topeka, KS113

By condition

Eligibility and exclusions, condition by condition

Alcoholic Liver Disease in Fayetteville Bladder Issues Due To Spinal Cord Injury in Fayetteville All conditions

More of AR

Little Rock513

New paid studies open every week

Get an email when a new clinical trial starts recruiting within 30 miles of your ZIP code. No spam — only real studies from the NIH registry.

By subscribing you agree to receive study alert emails. Unsubscribe anytime in one click.

Get free trial alerts